Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Carmen Marín-Bañasco"'
Autor:
Carolina Melero-Jerez, Margarita Suardíaz, Rafael Lebrón-Galán, Carmen Marín-Bañasco, Begoña Oliver-Martos, Isabel Machín-Díaz, Óscar Fernández, Fernando de Castro, Diego Clemente
Publikováno v:
Neurobiology of Disease, Vol 127, Iss , Pp 13-31 (2019)
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the human central nervous system (CNS), mainly affecting young adults. Among the immunomodulatory disease modifying treatments approved up to date to treat MS, IFN-β remains to be one
Externí odkaz:
https://doaj.org/article/bdc793728b8c483382a1b841c1b6bc71
Autor:
Rafael Lebrón-Galán, Fernando de Castro, Margarita Suardíaz, Oscar Fernandez, Carolina Melero-Jerez, Isabel Machín-Díaz, Begoña Oliver-Martos, Diego Clemente, Carmen Marín-Bañasco
Publikováno v:
Neurobiology of Disease, Vol 127, Iss, Pp 13-31 (2019)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the human central nervous system (CNS), mainly affecting young adults. Among the immunomodulatory disease modifying treatments approved up to date to treat MS, IFN-β remains to be one
Autor:
Karim Benabdellah, Carmen Marín-Bañasco, Begoña Oliver, F. de Castro, Isaac Hurtado-Guerrero, M.J. Pinto-Medel, Diego Clemente, Laura Leyva, Margarita Suardíaz, Oscar Fernández, F Martin, Carolina Melero-Jerez
Publikováno v:
British Journal of Pharmacology. 174:238-253
Background and Purpose Recombinant IFNs is one of the first line treatments in multiple sclerosis (MS), despite its lack of efficiency in some patients. In this context, mesenchymal stem cells (MSCs) represent a promising therapeutic alternative due
Autor:
Isaac Hurtado-Guerrero, José Pavia, Begoña Oliver, Margarita Suardíaz, Diego Clemente, Oscar Fernández, Laura Leyva, T. Orpez, M.J. Pinto-Medel, Carmen Marín-Bañasco, F. de Castro
Publikováno v:
Neuropharmacology. 110:480-492
Endogenous interferon beta (IFNβ) is an important cytokine involved in several chronic inflammatory diseases, such as Multiple Sclerosis (MS). In spite of the numerous therapeutic approaches available for MS patients, the administration of recombina
Autor:
María Jesús Pinto-Medel, Begoña Oliver-Martos, Carmen Marín-Bañasco, Carlos Arnáiz-Urrutia, Oscar Fernandez, Laura Leyva, G. Luque, Juan Antonio García-León, Teresa Órpez, Carlos López-Gómez
Publikováno v:
Journal of Neuroimmunology. 243:1-11
Multiple sclerosis (MS) is a chronic debilitating disease, in which T-cells are considered to play a pivotal role. CD28 is the quintessential costimulatory molecule on T-cells and its expression declines progressively with repeated stimulations, lead
Autor:
Rafael Maldonado Sánchez, Carmen Marín-Bañasco, Margarita Suardíaz García, Issac Hurtado Guerrero, Guillermo Estivill-Torrús, Laura Leyva Fernández, Oscar Fernández
Publikováno v:
Stem Cell Research & Therapy
Introduction Mesenchymal stem cells (MSCs) are a multipotent population of adult stem cells, which may represent a promising therapeutic approach for neurological autoimmune diseases such as multiple sclerosis. The mouse is the most used species for
Autor:
Carlos López-Gómez, Oscar Fernandez, Juan Antonio García-León, Teresa Órpez-Zafra, Begoña Oliver-Martos, Virginia Reyes-Garrido, Laura Leyva, Carmen Marín-Bañasco
Publikováno v:
CNS drugs. 28(6)
Both the adaptative and the innate immune systems interplay in multiple sclerosis (MS) pathogeny. Killer-cell immunoglobulin-like receptors (KIRs) are key regulators of the immune response, with activating and inhibitory isoforms.In this study we ana
Autor:
Begoña Oliver-Martos, Carmen Marín-Bañasco, María Jesús Pinto-Medel, Rafael Maldonado-Sanchez, Isidro Prat-Arrojo, Lucía García-Trujillo, Juan Antonio García-León, Óscar Fernández-Fernández, Laura Leyva-Fernández, Carlos López-Gómez, Margarita Suardíaz-García
Publikováno v:
Molecular immunology. 48(15-16)
Killer cell immunoglobulin-like receptors (KIRs) are regulators of cytolytic activity of natural killer and certain T cells through interactions with human leukocyte antigen (HLA) class I ligands. KIRs have been shown to contribute to the pathogenesi
Autor:
Carmen Marín-Bañasco, Margarita Suardíaz García, Laura Leyva Fernández, Begoña Oliver Martos, Oscar Fernández, María Jesús Pinto Medel, Karim Benabdellah, Francisco Martín Molina
Publikováno v:
Journal of Neuroimmunology. 275:194